Oncology patients’ perspectives on remote patient monitoring for COVID-19 Journal Article
| Authors: | Daly, B.; Lauria, T. S.; Holland, J. C.; Garcia, J.; Majeed, J.; Walters, C. B.; Zablocki, M.; Chow, K.; Strachna, O.; Giles, C. E.; Kelly, M. F.; Housen, A.; Canavan, M.; Maresca, N. M.; Baser, R.; Salvaggio, R.; Robson, M. E.; Reidy-Lagunes, D. L. |
| Article Title: | Oncology patients’ perspectives on remote patient monitoring for COVID-19 |
| Abstract: | PURPOSE Oncology patients are vulnerable to adverse outcomes associated with COVID-19, and clinical deterioration must be identified early. Several institutions launched remote patient monitoring programs (RPMPs) to care for patients with COVID-19. We describe patients’ perspectives on a COVID-19 RPMP at a National Comprehensive Cancer Center. METHODS Patients who tested positive for COVID-19 were eligible. Enrolled patients received a daily electronic COVID-19 symptom assessment, and a subset of high-risk patients also received a pulse oximeter. Monitoring was provided by a centralized team and was discontinued 14 days after a patient’s positive test result and following 3 days without worsening symptoms. Patients who completed at least one assessment and exited the program were sent a patient engagement survey to evaluate the patient’s experience with digital monitoring for COVID-19. RESULTS The survey was distributed to 491 patients, and 257 responded (52% completion rate). The net promoter score was 85%. Most patients agreed that the RPMP was worthwhile, enabled better management of their COVID-19 symptoms, made them feel more connected to their healthcare team, and helped prevent emergency room visits. Identified themes regarding patient-perceived value of a RPMP included (1) security: a clinical safety net; (2) connection: a link to their clinical team during a period of isolation; and (3) empowerment: an education on the virus and symptom management. CONCLUSION RPMPs are perceived to be of value to oncology patients with COVID-19. Policymakers should consider how these programs can be reimbursed to keep vulnerable patients at home and out of the acute care setting. Copyright © 2021 American Society of Clinical Oncology. All rights reserved. |
| Journal Title: | JCO Oncology Practice |
| Volume: | 17 |
| Issue: | 9 |
| ISSN: | 2688-1527 |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-09-01 |
| Start Page: | e1278 |
| End Page: | e1285 |
| Language: | English |
| DOI: | 10.1200/op.21.00269 |
| PUBMED: | 34085536 |
| PROVIDER: | scopus |
| PMCID: | PMC8457795 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 1 October 2021 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work